These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21156265)

  • 21. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse.
    Horner BR; Scheibe KE
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood and adolescent attention-deficit hyperactivity disorder: diagnosis, clinical practice guidelines, and social implications.
    Salmeron PA
    J Am Acad Nurse Pract; 2009 Sep; 21(9):488-97. PubMed ID: 19845806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study.
    Biederman J; Wilens T; Mick E; Faraone SV; Weber W; Curtis S; Thornell A; Pfister K; Jetton JG; Soriano J
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):21-9. PubMed ID: 9000777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
    Wilens TE; Biederman J
    J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Attention-deficit hyperactivity disorder and alcohol dependence: a risk constellation].
    Johann M; Bobbe G; Laufkötter R; Lange K; Wodarz N
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S102-4. PubMed ID: 15570519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do stimulants for ADHD lead to abuse later on?
    Child Health Alert; 2003 Feb; 21():1. PubMed ID: 12638512
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2004; 65 Suppl 3():3-7. PubMed ID: 15046528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
    Riggs PD; Leon SL; Mikulich SK; Pottle LC
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1271-8. PubMed ID: 9847499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
    Cotlar MJ
    J Insur Med; 2003; 35(1):51-6. PubMed ID: 14694825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathways from ADHD to early drug use.
    Chilcoat HD; Breslau N
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1347-54. PubMed ID: 10560220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.